메뉴 건너뛰기




Volumn 27, Issue 5, 2016, Pages 436-438

Interleukin-1 receptor antagonist (anakinra) for Schnitzler syndrome

Author keywords

anakinra; interleukin 1 receptor antagonist; Schnitzler syndrome

Indexed keywords

ANTIHISTAMINIC AGENT; ANTINUCLEAR ANTIBODY; C REACTIVE PROTEIN; CANAKINUMAB; COLCHICINE; CORTICOSTEROID; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN; IMMUNOGLOBULIN M; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; MITOCHONDRION ANTIBODY; PREDNISONE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RILONACEPT; TUMOR NECROSIS FACTOR INHIBITOR; ANTIRHEUMATIC AGENT; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

EID: 84958551621     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.3109/09546634.2015.1136048     Document Type: Article
Times cited : (10)

References (17)
  • 1
    • 0035157377 scopus 로고    scopus 로고
    • The Schnitzler syndrome. Four new cases and review of the literature
    • D.Lipsker, Y.Veran, F.Grunenberger, The Schnitzler syndrome. Four new cases and review of the literature. Medicine 2001;80:37–44
    • (2001) Medicine , vol.80 , pp. 37-44
    • Lipsker, D.1    Veran, Y.2    Grunenberger, F.3
  • 2
    • 84876685876 scopus 로고    scopus 로고
    • Schnitzler’s syndrome: diagnosis, treatment, and follow-up
    • A.Simon, B.Asli, M.Braun-Falco, Schnitzler’s syndrome:diagnosis, treatment, and follow-up. Allergy 2013;68:562–8
    • (2013) Allergy , vol.68 , pp. 562-568
    • Simon, A.1    Asli, B.2    Braun-Falco, M.3
  • 3
    • 36348963104 scopus 로고    scopus 로고
    • Schnitzler syndrome: beyond the case reports: review and follow-up of 94 patients with an emphasis on prognosis and treatment
    • H.D.de Koning, E.J.Bodar, J.W.van der Meer, Schnitzler syndrome:beyond the case reports:review and follow-up of 94 patients with an emphasis on prognosis and treatment. Semin Arthritis Rheum. 2007;37:137–48
    • (2007) Semin Arthritis Rheum , vol.37 , pp. 137-148
    • de Koning, H.D.1    Bodar, E.J.2    van der Meer, J.W.3
  • 4
    • 84908146365 scopus 로고    scopus 로고
    • Long-term effectiveness and safety of interleukin-1 receptor antagonist (anakinra) in Schnitzler’s syndrome: a French multicenter study
    • A.Néel, B.Henry, S.Barbarot, Long-term effectiveness and safety of interleukin-1 receptor antagonist (anakinra) in Schnitzler’s syndrome:a French multicenter study. Autoimmun Rev. 2014;13:1035–41
    • (2014) Autoimmun Rev , vol.13 , pp. 1035-1041
    • Néel, A.1    Henry, B.2    Barbarot, S.3
  • 5
    • 84883790466 scopus 로고    scopus 로고
    • Sustained efficacy of the monoclonal anti-interleukin-1 beta antibody canakinumab in a 9-month trial in Schnitzler’s syndrome
    • H.D.de Koning, J.Schalkwijk, J.van der Ven-Jongekrijg, Sustained efficacy of the monoclonal anti-interleukin-1 beta antibody canakinumab in a 9-month trial in Schnitzler’s syndrome. Ann Rheum Dis. 2013;72:1634–8
    • (2013) Ann Rheum Dis , vol.72 , pp. 1634-1638
    • de Koning, H.D.1    Schalkwijk, J.2    van der Ven-Jongekrijg, J.3
  • 6
    • 84862010053 scopus 로고    scopus 로고
    • Efficacy and safety of the interleukin-1 antagonist rilonacept in Schnitzler syndrome: an open-label study
    • K.Krause, K.Weller, R.Stefaniak, Efficacy and safety of the interleukin-1 antagonist rilonacept in Schnitzler syndrome:an open-label study. Allergy 2012;67:943–50
    • (2012) Allergy , vol.67 , pp. 943-950
    • Krause, K.1    Weller, K.2    Stefaniak, R.3
  • 7
    • 22244467732 scopus 로고    scopus 로고
    • Successful treatment of refractory Schnitzler syndrome with anakinra: comment on the article by Hawkins et al
    • V.M.Martinez-Taboada, A.Fontalba, R.Blanco, J.L.Fernández-Luna Successful treatment of refractory Schnitzler syndrome with anakinra:comment on the article by Hawkins et al. Arthritis Rheum. 2005;52:2226–7
    • (2005) Arthritis Rheum , vol.52 , pp. 2226-2227
    • Martinez-Taboada, V.M.1    Fontalba, A.2    Blanco, R.3    Fernández-Luna, J.L.4
  • 8
    • 79952266366 scopus 로고    scopus 로고
    • Treatment of Schnitzler’s syndrome with anakinra: report of three cases and review of the literature
    • J.T.Gran, Ø.Midtvedt, S.Haug, P.Aukrust Treatment of Schnitzler’s syndrome with anakinra:report of three cases and review of the literature. Scand J Rheumatol. 2011;40:74–9
    • (2011) Scand J Rheumatol , vol.40 , pp. 74-79
    • Gran, J.T.1    Midtvedt, Ø.2    Haug, S.3    Aukrust, P.4
  • 9
    • 78649781218 scopus 로고    scopus 로고
    • The Schnitzler syndrome
    • D.Lipsker The Schnitzler syndrome. Orphanet J Rare Dis. 2010;5:38. doi:10.1186/1750-1172-5-38
    • (2010) Orphanet J Rare Dis , vol.5 , pp. 38
    • Lipsker, D.1
  • 10
    • 84864545087 scopus 로고    scopus 로고
    • Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases
    • C.A.Dinarello, A.Simon, J.W.van der Meer Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases. Nat Rev Drug Discov. 2012;11:633–52
    • (2012) Nat Rev Drug Discov , vol.11 , pp. 633-652
    • Dinarello, C.A.1    Simon, A.2    van der Meer, J.W.3
  • 11
    • 34447267950 scopus 로고    scopus 로고
    • Schnitzler syndrome: treatment failure to rituximab but response to anakinra
    • E.Eiling, M.Möller, I.Kreiselmaier, Schnitzler syndrome:treatment failure to rituximab but response to anakinra. J Am Acad Dermatol. 2007;57:361–4
    • (2007) J Am Acad Dermatol , vol.57 , pp. 361-364
    • Eiling, E.1    Möller, M.2    Kreiselmaier, I.3
  • 12
    • 84863430275 scopus 로고    scopus 로고
    • Dermal interleukin-1 expression and effective and long-lasting therapy with interleukin-1 receptor antagonist anakinra in Schnitzler syndrome
    • T.Volz, F.Wölbing, J.Fischer, Dermal interleukin-1 expression and effective and long-lasting therapy with interleukin-1 receptor antagonist anakinra in Schnitzler syndrome. Acta Derm Venereol. 2012;92:393–4
    • (2012) Acta Derm Venereol , vol.92 , pp. 393-394
    • Volz, T.1    Wölbing, F.2    Fischer, J.3
  • 13
    • 18644374105 scopus 로고    scopus 로고
    • Blocking IL-1 in systemic inflammation
    • C.A.Dinarello Blocking IL-1 in systemic inflammation. J Exp Med. 2005;201:1355–9
    • (2005) J Exp Med , vol.201 , pp. 1355-1359
    • Dinarello, C.A.1
  • 15
    • 38149024742 scopus 로고    scopus 로고
    • IL-1 blockade in Schnitzler syndrome: ex vivo findings correlate with clinical remission
    • J.G.Ryan, H.D.de Koning, L.A.Beck, IL-1 blockade in Schnitzler syndrome:ex vivo findings correlate with clinical remission. J Allergy Clin Immunol. 2008;121:260–2
    • (2008) J Allergy Clin Immunol , vol.121 , pp. 260-262
    • Ryan, J.G.1    de Koning, H.D.2    Beck, L.A.3
  • 16
    • 84978022581 scopus 로고    scopus 로고
    • Schnitzler’s syndrome: lessons from 281 cases
    • H.D.de Koning Schnitzler’s syndrome:lessons from 281 cases. Clin Transl Allergy. 2014;4:41
    • (2014) Clin Transl Allergy , vol.4 , pp. 41
    • de Koning, H.D.1
  • 17
    • 79551572464 scopus 로고    scopus 로고
    • [A woman with recurrent urticaria, joint pain and fever]
    • J.T.Gran, Ø.Midtvedt, S.Haug [A woman with recurrent urticaria, joint pain and fever]. Tidsskr nor Laegeforen. 2011;131:135–6
    • (2011) Tidsskr nor Laegeforen , vol.131 , pp. 135-136
    • Gran, J.T.1    Midtvedt, Ø.2    Haug, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.